178 related articles for article (PubMed ID: 36857950)
21. The role of a family history of psychosis for youth at clinical high risk of psychosis.
Georgopoulos G; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Early Interv Psychiatry; 2019 Apr; 13(2):251-256. PubMed ID: 28792113
[TBL] [Abstract][Full Text] [Related]
22. Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.
Yang LH; Link BG; Ben-David S; Gill KE; Girgis RR; Brucato G; Wonpat-Borja AJ; Corcoran CM
Schizophr Res; 2015 Oct; 168(1-2):9-15. PubMed ID: 26314731
[TBL] [Abstract][Full Text] [Related]
23. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
[TBL] [Abstract][Full Text] [Related]
24. Neighborhood crime, socioeconomic status, and suspiciousness in adolescents and young adults at Clinical High Risk (CHR) for psychosis.
Vargas T; Rakhshan Rouhakhtar PJ; Schiffman J; Zou DS; Rydland KJ; Mittal VA
Schizophr Res; 2020 Jan; 215():74-80. PubMed ID: 31759810
[TBL] [Abstract][Full Text] [Related]
25. Demographic correlates of attenuated positive psychotic symptoms.
Waford RN; MacDonald A; Goines K; Novacek DM; Trotman HD; Elaine F W; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; Mathalon DH; Tsuang MT; Perkins DO; Seidman LJ; Woods SW; McGlashan TH
Schizophr Res; 2015 Aug; 166(1-3):31-6. PubMed ID: 25999040
[TBL] [Abstract][Full Text] [Related]
26. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
[TBL] [Abstract][Full Text] [Related]
27. Family history of psychosis in youth at clinical high risk: A replication study.
Santesteban-Echarri O; Sandel D; Liu L; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
Psychiatry Res; 2022 May; 311():114480. PubMed ID: 35245743
[TBL] [Abstract][Full Text] [Related]
28. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
Carrión RE; Auther AM; McLaughlin D; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman L; Stone W; Tsuang M; Walker EF; Woods SW; Torous J; Cornblatt BA
Schizophr Res; 2021 Jan; 227():44-51. PubMed ID: 33131983
[TBL] [Abstract][Full Text] [Related]
29. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
[TBL] [Abstract][Full Text] [Related]
30. Core Schemas in Youth at Clinical High Risk for Psychosis.
Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Heinssen R; Addington J
Behav Cogn Psychother; 2016 Mar; 44(2):203-13. PubMed ID: 25896713
[TBL] [Abstract][Full Text] [Related]
31. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
[TBL] [Abstract][Full Text] [Related]
32. Within-Person Relationship between Attenuated Positive Symptoms and Suicidal Ideation among Individuals at Clinical High Risk for Psychosis.
Wastler HM; Cowan HR; Hamilton SA; Lundin NB; Manges M; Moe AM; Breitborde NJK
Arch Suicide Res; 2023 Oct; ():1-14. PubMed ID: 37840314
[TBL] [Abstract][Full Text] [Related]
33. Associations between childhood ethnoracial minority density, cortical thickness, and social engagement among minority youth at clinical high-risk for psychosis.
Ku BS; Collins M; Anglin DM; Diomino AM; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Druss BG; Keshavan M; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Walker EF
Neuropsychopharmacology; 2023 Nov; 48(12):1707-1715. PubMed ID: 37438421
[TBL] [Abstract][Full Text] [Related]
34. Family communication and the efficacy of family focused therapy in individuals at clinical high risk for psychosis with comorbid anxiety.
O'Brien Cannon AC; Caporino NE; O'Brien MP; Miklowitz DJ; Addington JM; Cannon TD
Early Interv Psychiatry; 2023 Mar; 17(3):281-289. PubMed ID: 35719024
[TBL] [Abstract][Full Text] [Related]
35. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
[TBL] [Abstract][Full Text] [Related]
36. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
Ryan AT; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD; Walker EF
Schizophr Res; 2018 Jul; 197():522-530. PubMed ID: 29279247
[TBL] [Abstract][Full Text] [Related]
37. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.
Zaks N; Velikonja T; Parvaz MA; Zinberg J; Done M; Mathalon DH; Addington J; Cadenhead K; Cannon T; Cornblatt B; McGlashan T; Perkins D; Stone WS; Tsuang M; Walker E; Woods SW; Keshavan MS; Buysse DJ; Velthorst E; Bearden CE
Schizophr Bull; 2022 Jan; 48(1):111-121. PubMed ID: 34536012
[TBL] [Abstract][Full Text] [Related]
38. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort.
Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH
Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912
[TBL] [Abstract][Full Text] [Related]
39. Perceived social stress and symptom severity among help-seeking adolescents with versus without clinical high-risk for psychosis.
Millman ZB; Pitts SC; Thompson E; Kline ER; Demro C; Weintraub MJ; DeVylder JE; Mittal VA; Reeves GM; Schiffman J
Schizophr Res; 2018 Feb; 192():364-370. PubMed ID: 28629890
[TBL] [Abstract][Full Text] [Related]
40. Changes in core beliefs over time predict symptoms and functioning in clinical high risk for psychosis.
Patton HN; Cowan HR; Mittal VA
Early Interv Psychiatry; 2022 Mar; 16(3):311-315. PubMed ID: 33938147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
